5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.02▲ | 3.99▲ | 4.02▲ | 4.00▲ | 3.71▲ |
MA10 | 3.99▲ | 4.05▲ | 4.07▲ | 3.79▲ | 3.55▲ |
MA20 | 4.02▲ | 4.06▲ | 3.99▲ | 3.67▲ | 3.19▲ |
MA50 | 4.07▲ | 3.95▲ | 3.83▲ | 3.50▲ | 3.14▲ |
MA100 | 3.97▲ | 3.75▲ | 3.66▲ | 3.11▲ | 4.80▼ |
MA200 | 3.84▲ | 3.67▲ | 3.56▲ | 3.19▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.014▲ | -0.014▼ | -0.010▼ | 0.053▲ | 0.105▲ |
RSI | 61.996▲ | 59.275▲ | 61.808▲ | 64.678▲ | 60.883▲ |
STOCH | 68.676 | 30.338 | 48.315 | 84.954▲ | 75.636 |
WILL %R | 0.000▲ | -20.000▲ | -14.286▲ | -7.692▲ | -4.795▲ |
CCI | 226.597▲ | 52.037 | 65.455 | 130.758▲ | 191.158▲ |
Wednesday, September 03, 2025 04:40 PM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Genelux Corp. ( (GNLX)) just unveiled an ...
|
Tuesday, September 02, 2025 01:25 PM
Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference or contact genelux@allelecomms.com About Genelux Corporation Genelux is a late ...
|
Tuesday, September 02, 2025 01:02 PM
Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/09/25 | 3.995 | 4.14 | 3.995 | 4.14 | 45,176 |
17/09/25 | 4.03 | 4.21 | 3.90 | 3.91 | 171,650 |
16/09/25 | 3.93 | 4.14 | 3.764 | 4.09 | 289,944 |
15/09/25 | 3.97 | 4.00 | 3.82 | 3.92 | 164,120 |
12/09/25 | 3.67 | 4.00 | 3.58 | 3.95 | 294,287 |
11/09/25 | 3.69 | 3.75 | 3.56 | 3.65 | 112,022 |
10/09/25 | 3.67 | 3.73 | 3.5865 | 3.65 | 60,683 |
09/09/25 | 3.59 | 3.70 | 3.48 | 3.67 | 74,848 |
08/09/25 | 3.40 | 3.59 | 3.36 | 3.56 | 370,594 |
05/09/25 | 3.49 | 3.55 | 3.36 | 3.37 | 446,122 |
|
|
||||
|
|
||||
|
|